Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-Label Extension Study of Pitolisant in Prader-Willi Syndrome
NCT07219485Phase 3Enrolling by invitation
- Sponsor
- Harmony Biosciences
- Start
- Aug 2025
- Primary completion
- Aug 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pitolisant in Prader-Willi syndrome (PWS), sponsored by Harmony Biosciences. Started Aug 2025; status: enrolling by invitation.
02
Drugs
pitolisant
03
Conditions
Prader-Willi syndrome (PWS)
Beyond the preview
Go deeper on NCT07219485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07219485.